Biome’s Q3 trading update highlighted a delay in the shipping of one of the three major RF orders that were scheduled for delivery in H2 FY24. The slippage of this contract into FY25, coupled with delays to the expected ramp-up at one of Bioplastics’ end customers has led us to reduce expectations for FY24. While the former issue will result in higher FY25 revenues in RF, the latter encourages us to add some more caution into our FY25 forecasts for Bioplastics. Overall, Group adjusted LBT for FY ....
